Neuronal-Type Specific SNCA-Targeted Epigenome Therapy for Precision Medicine in Synucleinopathies
Conferences
O'Donovan, B; Sun, Z; Kantor, B; Chiba-Falek, O
Published in: MOLECULAR THERAPY
April 22, 2024
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
April 22, 2024
Volume
32
Issue
4
Start / End Page
531 / 532
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
Citation
APA
Chicago
ICMJE
MLA
NLM
O’Donovan, B., Sun, Z., Kantor, B., & Chiba-Falek, O. (2024). Neuronal-Type Specific SNCA-Targeted Epigenome Therapy for Precision Medicine in Synucleinopathies. In MOLECULAR THERAPY (Vol. 32, pp. 531–532).
O’Donovan, Bernadette, Zhiguo Sun, Boris Kantor, and Ornit Chiba-Falek. “Neuronal-Type Specific SNCA-Targeted Epigenome Therapy for Precision Medicine in Synucleinopathies.” In MOLECULAR THERAPY, 32:531–32, 2024.
O’Donovan B, Sun Z, Kantor B, Chiba-Falek O. Neuronal-Type Specific SNCA-Targeted Epigenome Therapy for Precision Medicine in Synucleinopathies. In: MOLECULAR THERAPY. 2024. p. 531–2.
O’Donovan, Bernadette, et al. “Neuronal-Type Specific SNCA-Targeted Epigenome Therapy for Precision Medicine in Synucleinopathies.” MOLECULAR THERAPY, vol. 32, no. 4, 2024, pp. 531–32.
O’Donovan B, Sun Z, Kantor B, Chiba-Falek O. Neuronal-Type Specific SNCA-Targeted Epigenome Therapy for Precision Medicine in Synucleinopathies. MOLECULAR THERAPY. 2024. p. 531–532.
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
April 22, 2024
Volume
32
Issue
4
Start / End Page
531 / 532
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics